Cargando…
Immunoinformatics Approach to Design a Novel Subunit Vaccine Against Visceral Leishmaniasis
Visceral leishmaniasis (VL) infection is mostly caused by Leishmania donovani and affects countries worldwide. Despite the need for a safe and effective vaccine against leishmaniasis due to the increased drug resistance, however, no vaccine has yet been licensed for clinical use. This study revolves...
Autores principales: | Lari, Alireza, Lari, Niloofar, Biabangard, Atefeh |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer Netherlands
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8675112/ https://www.ncbi.nlm.nih.gov/pubmed/34931120 http://dx.doi.org/10.1007/s10989-021-10344-3 |
Ejemplares similares
-
In silico designing of a novel polyvalent multi-subunit peptide vaccine leveraging cross-immunity against human visceral and cutaneous leishmaniasis: an immunoinformatics-based approach
por: Bhattacharjee, Mainak, et al.
Publicado: (2023) -
Designing of a Novel Fusion Protein Vaccine Candidate Against Human Visceral Leishmaniasis (VL) Using Immunoinformatics and Structural Approaches
por: Atapour, Amir, et al.
Publicado: (2021) -
Immunoinformatics Approach to Design Novel Subunit Vaccine against the Epstein-Barr Virus
por: Moin, Abu Tayab, et al.
Publicado: (2022) -
Immunoinformatics Approach to Design a Multi-Epitope Vaccine against Cutaneous Leishmaniasis
por: Naz, Shumaila, et al.
Publicado: (2023) -
Chimeric Vaccines Designed by Immunoinformatics-Activated Polyfunctional and Memory T cells that Trigger Protection against Experimental Visceral Leishmaniasis
por: De Brito, Rory Cristiane Fortes, et al.
Publicado: (2020)